Wendell never imagined one day he’d need a new heart. At 37, the active father from Florence, Kentucky, enjoyed his life with his wife, Angie, and young son, Isaiah. But when he started experiencing shortness of breath, he knew something might be wrong.
Not feeling any chest pain or any other symptoms, Wendell went to his primary care physician, who prescribed an inhaler for him. After the inhaler didn’t work, his doctor recommended Wendell get a stress test. When the results came back, both Wendell and his doctor were shocked to find out he had only 10 percent blood flow to his heart. Wendell was immediately referred to Dr. Chung, a congestive heart failure specialist at Christ Hospital in Cincinnati.
Here for a Reason
Wendell reflects on finding out about the seriousness of his condition and what might have been.
Felt like Home
Angie talks about the Unverferth House, Ohio State's on-campus residence for the families of heart patients.
Meeting Dr. Chung
Wendell speaks with Dr. Eugene Chung, the cardiologist who referred him to Ohio State.
My New Heart
Wendell speaks with Dr. Juan Crestanello about getting a second chance at life.
Wendell talks with Dr. Ayesha Hasan, a cardiologist at Ohio State, about his early symptoms.
His surprising diagnosis "I knew something was wrong, but I didn't know it was that serious."
A heart transplant was unavoidable "Ohio State was the best place for me."
He's amazed he's still alive "I'm still here for a reason."
Why choose Ohio State for heart failure care?
Since completing our first heart transplant in 1986, The Ohio State University Wexner Medical Center has been the only adult heart transplant center in central Ohio. Ohio State’s Richard M. Ross Heart Hospital is consistantly recognized as a leader in heart care and heart surgery in U.S.News & World Report. We focus on the physical, psychological, emotional and social needs of patients with end-stage heart disease, through transplantation to post-transplant care.
Our researchers were among the first in the nation to evaluate the use of cyclosporine, a drug that suppresses the immune system and dramatically improves the success of organ transplantation. Our research teams are currently studying new methods to lengthen the amount of time a heart remains viable for transplantation and are constantly exploring new ways to improve the transplant experience for patients.